Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Nov 16, 2015
Emerging Company Profile
Bridge to POC
...or collaborating with other companies," said CEO Haishan Jang. Jang was senior director at J&J's
Centocor
...
Read More
BioCentury
|
Jun 16, 2014
Finance
Biotech rating scheme
...2013: Chairman and CEO of Coronado Biosciences Inc. (NASDAQ:CNDO); 1990-2012: Johnson & Johnson (NYSE:JNJ) and
Centocor Inc.
...
Read More
BioCentury
|
Sep 30, 2013
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
Aug 12, 2013
Finance
Abiding no more
...to Gansu Duyiwei Biotechnology Co. Ltd. Apexigen also has deals to create mAbs for the
Centocor
...
Read More
BioCentury
|
Aug 5, 2013
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
May 20, 2013
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
May 20, 2013
Company News
Aveo Pharmaceuticals, J&J deal
...Aveo disclosed in a 10-Q filing that Johnson & Johnson's Janssen Biotech Inc. (formerly
Centocor
Ortho...
Read More
BioCentury
|
Jul 23, 2012
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
Jun 28, 2012
Targets & Mechanisms
Fragmentary progress in endometriosis
...2008, researchers from University Hospitals Leuven, the University of Oxford and Johnson & Johnson 's
Centocor Inc.
...
Read More
BioCentury
|
Jun 18, 2012
Clinical News
Simponi golimumab: Phase III data
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
Items per page:
10
1 - 10 of 860
BioCentury
|
Nov 16, 2015
Emerging Company Profile
Bridge to POC
...or collaborating with other companies," said CEO Haishan Jang. Jang was senior director at J&J's
Centocor
...
Read More
BioCentury
|
Jun 16, 2014
Finance
Biotech rating scheme
...2013: Chairman and CEO of Coronado Biosciences Inc. (NASDAQ:CNDO); 1990-2012: Johnson & Johnson (NYSE:JNJ) and
Centocor Inc.
...
Read More
BioCentury
|
Sep 30, 2013
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
Aug 12, 2013
Finance
Abiding no more
...to Gansu Duyiwei Biotechnology Co. Ltd. Apexigen also has deals to create mAbs for the
Centocor
...
Read More
BioCentury
|
Aug 5, 2013
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
May 20, 2013
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
May 20, 2013
Company News
Aveo Pharmaceuticals, J&J deal
...Aveo disclosed in a 10-Q filing that Johnson & Johnson's Janssen Biotech Inc. (formerly
Centocor
Ortho...
Read More
BioCentury
|
Jul 23, 2012
Clinical News
Simponi golimumab regulatory update
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
BioCentury
|
Jun 28, 2012
Targets & Mechanisms
Fragmentary progress in endometriosis
...2008, researchers from University Hospitals Leuven, the University of Oxford and Johnson & Johnson 's
Centocor Inc.
...
Read More
BioCentury
|
Jun 18, 2012
Clinical News
Simponi golimumab: Phase III data
...over a dispute related to a 1998 deal between J&J's Janssen Biotech Inc. unit (formerly
Centocor
...
Read More
Items per page:
10
1 - 10 of 860
Previous page
Next page